In this podcast, Charles Bernstein, MD, speaks about psychiatric comorbidities that occur in patients with Crohn disease and how they differ from other IBD disorders, the collaboration necessary within the...
In this episode, W. Clay Jackson, MD, DipTH, speaks about the differences between schizophrenia and dissociative identity disorder, how patients with schizophrenia should be managed, and the gaps in the...
Hannah Wulczyn, MPA, discusses the Computerized Adaptive Screen for Suicidal Youth, or CASSY, the first-of-its-kind screening tool used for suicide risk in pediatric emergency departments.
In this episode, Margie Balfour, MD, PhD, of Connections Health Solutions, speaks about the challenges in launching the new 3-digit code for people experiencing a mental health crisis, including the...
In this episode, Margie Balfour, MD, PhD, speaks about the new 3-digit code for people experiencing a mental health crisis. Starting July 16, 2022, people can call or text 9-8-8 to be connected to a mental...
In this podcast, Nolan R. Williams, MD, discusses the Stanford Accelerated Intelligent Neuromodulation Therapy protocol, which reduced severe depression symptoms in 90% of participants in a small trial. ...
Rashi Aggarwal, MD, from Rutgers New Jersey Medical School, discusses screening tools and treatment options for diagnosing and managing posttraumatic stress disorder in the primary care setting.
In part 1 of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses the 5 criteria used to help diagnose schizophrenia, as well as the differential...
Dr Laitman discusses evidence supporting the reclassification of schizophrenia as a neurological disorder, his views on how reclassification could impact prognosis and recovery, and treatment interventions...
Jacob Miguel Vigil, PhD, discusses new study findings that suggest THC may confer more therapeutic benefit than CBD across many different health conditions, and why he says now is the “Golden Age” of...
